Indications › Type 1 diabetes › liraglutide

liraglutide in type 1 diabetes

liraglutide is not approved in the US for type 1 diabetes, and has 27 trials on file here in this condition. 17 of them are phase 3 or later. The next scheduled result is 2028-10-30. Being studied in a condition is not the same as being approved for it; most such programmes end without an approval.

27 registered trials study liraglutide (Saxenda, Victoza, Xultophy) in type 1 diabetes, 1 of them still active. None has a scheduled reporting date on file.

Trials on file: 27
Active: 1
Active phase 3: 0
Participants in active trials: 60
Sponsors: 13
Scheduled readouts: 0

All trials on file

Every registered trial of liraglutide grouped under type 1 diabetes, largest first. Grouping follows the registry’s own condition wording.

Trial	Status	Phase	Sponsor
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes NCT01836523	Completed	P3	Novo Nordisk A/S
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes NCT02098395	Completed	P3	Novo Nordisk A/S
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function NCT02443155	Completed	P2	Novo Nordisk A/S
GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients NCT01592279	Unknown	P4	Hadassah Medical Organization
Liraglutide in Type 1 Diabetes NCT01612468	Completed	P4	Steno Diabetes Center Copenhagen
Liraglutide In Overweight Patients With Type 1 Diabetes NCT01753362	Completed	P3	University at Buffalo
Liraglutide in the Treatment of Type 1 Diabetes Mellitus NCT01722266	Completed	P3	University at Buffalo
Liraglutide in Type 1 Diabetes NCT01722240	Completed	P3	University at Buffalo
Liraglutide in Newly Onset Type 1 Diabetes. NCT01879917	Completed	P2/P3	Hvidovre University Hospital
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619	Recruiting	P2	Mayo Clinic
The Lira Pump Trial NCT02351232	Completed	P2/P3	Hvidovre University Hospital
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults NCT02611232	Unknown	P2	University of Oulu
Liraglutide as add-on to Insulin in Type 1 Diabetes NCT02092896	Completed	P3	Hvidovre University Hospital
Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus NCT05467514	Completed	P3	David Sanchez Garcia
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes NCT02518945	Completed	P3	University at Buffalo
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus NCT03011008	Unknown	P4	Second Xiangya Hospital of Central South University
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting NCT01755416	Completed	P2	Albert Einstein College of Medicine
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes NCT02617654	Completed	P2	Per-Ola Carlsson
Incretin Effect on the Immunological Phenotype NCT01782261	Completed	P2	Medical University of Graz
52 Week Trial of Liraglutide in Type 1 Diabetes NCT01787916	Completed	P4	CHU de Quebec-Universite Laval
Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects NCT02408705	Completed	P2	Medical University of Graz
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes NCT02908087	Completed	P2	University of Oulu
Incretin-based Therapy in Late Preclinical Type 1 Diabetes NCT02898506	Completed	P2	University of Oulu
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate NCT02584582	Unknown	P2/P3	Hvidovre University Hospital
Liraglutide in Adolescents With Type 1 Diabetes NCT02516657	Completed	P3	University at Buffalo
Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation NCT01206101	Terminated	P2	Novo Nordisk A/S
Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes NCT01722227	Withdrawn	P3	University at Buffalo

See the full record for liraglutide, or every molecule being studied in type 1 diabetes. These are registered trials, nothing more. Most drugs tested in a new condition never get approved for it, and plenty of these will report nothing useful.